Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: A Phase II Safety and Tolerability Study With SEN0014196 [Phase 2]
Phase II safety and tolerability study of SEN0014196 for Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 [Phase 1]
A Phase 1 exploratory trial of SEN0014196 in early-stage Huntington's disease patients has completed, according to ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study [NA]
This document provides a clinical trial update on the feasibility of using video-oculography to assess Huntington's disease in the VOG-HD st…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study) [Phase 2]
A Phase 2 trial evaluating epigallocatechin gallate (EGCG) for Huntington disease has completed (ETON-Study), sponsored by Charité Universit…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study of the Novel Drug Dimebon in Patients With Huntington's Disease [Phase 2]
The document reports the completion of a Phase 2 clinical study evaluating Dimebon for Huntington's disease. No efficacy or safety results a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Minocycline in Patients With Huntington's Disease [Phase 1, Phase 2]
The document reports completion of a Phase 1/Phase 2 trial evaluating minocycline in patients with Huntington's disease.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Apathy Cure Through Bupropion in Huntington's Disease [Phase 2]
Phase 2 trial assessing whether bupropion can improve apathy in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability [Phase 2]
This Phase 2 extension study in premanifest Huntington's disease evaluated the safety and tolerability of creatine and has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Creatine Safety and Tolerability in Premanifest HD: PRECREST [Phase 2]
This Phase 2 study (PRECREST) evaluated the safety and tolerability of creatine in individuals with premanifest Huntington disease and has c…
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study [Phase 2]
Phase 2 extension study assessing safety and tolerability of creatine in premanifest Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Pilot Study of Minocycline in Huntington's Disease [Phase 2, Phase 3]
This document reports the posting of results from a Phase 2/Phase 3 pilot study of minocycline in Huntington's disease.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users [Phase 1]
Pfizer conducted a Phase 1 study to evaluate the abuse potential of single oral doses of dimebon (latrepirdine) in healthy recreational poly…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease [Phase 1]
A Phase 1 open-label study evaluating the effect of food on SEN0014196 in subjects with Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Citalopram to Enhance Cognition in HD [Phase 2]
A Phase 2 trial tested citalopram for cognitive enhancement in Huntington's disease; the study has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Neuroprotection by Cannabinoids in Huntington's Disease [Phase 2]
A Phase 2 Huntington's disease trial evaluating neuroprotection by cannabinoids has completed. The update does not include detailed results.
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: Creatine Safety & Tolerability in Huntington's Disease [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of creatine in Huntington's disease has completed, with results posted in December 20…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Atomoxetine and Huntington's Disease [Phase 2]
Phase 2 trial evaluating atomoxetine for Huntington's disease with chorea; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease [Phase 1]
Phase 1 trial evaluating deep brain stimulation of the globus pallidus in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [Phase 2]
Phase 2 safety and tolerability trial of phenylbutyrate in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Cognitive Assessment Battery (CAB) Beta Study
This trial update reports that the Cognitive Assessment Battery (CAB) Beta Study for Huntington's disease has completed, sponsored by CHDI F…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Riluzole in Huntington's Disease [Phase 3]
Sanofi-sponsored Phase 3 trial of riluzole for Huntington's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Escalating Dose Study in Healthy Volunteers With SEN0014196 [Phase 1]
Phase 1 escalating-dose study of SEN0014196 in healthy volunteers has completed; Huntington's disease is listed as the condition.
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea [Phase 2]
A Phase 2 trial evaluating mavoglurant (AFQ056) for reducing chorea in Huntington's disease was terminated. The update notes the study's sta…
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Effects of Music Therapy on Huntington's Disease [Phase 1]
Phase 1 clinical trial evaluating music therapy for Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin [Phase 1]
Phase 1 study evaluating systemic absorption of dimebon when applied as a skin solution in participants with Alzheimer's disease or Huntingt…